Health Headlines for Tuesday, February 7
From ‘Repeal’ to ‘Repair’: Campaign Talk on Health Law Meets Reality
New York Times
Asked at a confirmation hearing two weeks ago if he was working with President Trump on a secret plan to replace the Affordable Care Act, Representative Tom Price, Mr. Trump’s nominee for secretary of health and human services, smiled broadly and answered: “It’s true that he said that, yes.”
Albany to host state’s first hepatitis C summit
Albany Times Union
Public health officials, elected leaders, medical experts and patient advocates will gather this week for New York’s first-ever hepatitis C summit.
Faso on the Future of Healthcare
Time Warner Cable News
President Donald Trump this week acknowledged it is going to take time to properly replace the Affordable Care Act. When it comes to healthcare, it is an issue that both Democrats and Republicans are treading very cautiously about. Republican Congressman John Faso weighs in.
Trump administration weighs Obamacare changes sought by insurers
Politico
The Trump administration is considering major changes to Obamacare that may help convince insurers to remain in the law’s marketplaces while Congress drafts a replacement plan — but the proposals may also limit enrollment and increase costs for older Americans, according to documents obtained by POLITICO.
Ex-employees of state-licensed medical marijuana company charged with smuggling
Politico
Three former employees from Vireo Health, one of the five companies licensed to grow and sell medical marijuana in New York, were charged in Minnesota with smuggling the drug across state lines in an effort to help the company meet its production target for New York.
A New Device May Mean Fewer Breast-Cancer Surgeries
Wall Street Journal
A new device may hold the promise of eliminating an anguishing part of many breast-cancer surgeries: a follow-up operation to remove lingering cancer cells. Several surgeons are using a tool that shows promise in reducing the number of repeat procedures.
Mylan to Pay $96.5 Million to Settle Generic Provigil Claims
Bloomberg
Mylan NV agreed to pay $96.5 million to settle claims that the company conspired to delay a generic version of Cephalon Inc.’s Provigil drug in exchange for payment from the company.
Single mom in Brooklyn in desperate need of health insurance for sick son
PIX 11
She is now studying to be an EMT, but she needs us to save her and help her with her health insurance.